Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. (Q52024622)

20 April 2018

title

Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. (English)

1 reference

20 April 2018

0 references

R Ciccocioppo

1

1 reference

20 April 2018

S Angeletti

2

1 reference

20 April 2018

P P Sanna

3

1 reference

20 April 2018

F Weiss

4

1 reference

20 April 2018

M Massi

5

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 September 2000

1 reference

20 April 2018

European Journal of Pharmacology

published in

1 reference

20 April 2018

volume

404

1 reference

20 April 2018

issue

1-2

1 reference

20 April 2018

page(s)

153-159

1 reference

20 April 2018

SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Effect of nociceptin on alcohol intake in alcohol-preferring rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Neonatally administered naltrexone affects several behavioral responses in adult rats of both genders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

The role of dopamine in drug abuse viewed from the perspective of its role in motivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Opiate reinforcement and naloxone aversion, as revealed by place preference paradigm, in two strains of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Autoradiographic localization of [3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

The orphan opioid receptor and its endogenous ligand — nociceptin/orphanin FQ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Preexposure sensitizes rats to the rewarding effects of cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Structure and regional distribution of nociceptin/orphanin FQ precursor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Neuroscience of addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Absence of opiate rewarding effects in mice lacking dopamine D2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Nociceptin system plays a role in the memory retention: involvement of naloxone benzoylhydrazone binding sites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Orphanin FQ is a functional anti-opioid peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Orphanin FQ/nociceptin blocks acquisition of morphine place preference.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Primary structure and tissue distribution of the orphanin FQ precursor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Naltrexone-induced aversions: assessment by place conditioning, taste reactivity, and taste avoidance paradigms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Structure-activity relationship studies on the novel neuropeptide orphanin FQ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

The neural basis of drug craving: an incentive-sensitization theory of addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

The dopamine hypothesis of reward: past and current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900590-2

10.1016/S0014-2999(00)00590-2

7 January 2021

Identifiers

DOI

1 reference

20 April 2018

release_di47n6y2ozbkraljagfniq3twa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/di47n6y2ozbkraljagfniq3twa

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

10980274

1 reference

20 April 2018